Pharmaceutical Membrane Filtration Market Insight and Trends 2027
The global Pharmaceutical Membrane Filtration market gathered revenue around USD 6.2 Billion in 2020 and market is set to grow USD 14.2 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 16.5% during the prediction period 2021 to 2027.
Growth Factors:
The industry has gained considerable momentum due to implementation of single use technologies in pharmaceutical sector. Moreover, innovations in nanofiltration technologies, coupled with quick adoption of advanced treatment therapies involving monoclonal antibodies, therapeutic proteins, and new vaccines has accelerated the use of filtration systems with membranes, capsules, cartridges among biopharmaceutical and biotechnology companies.
Proceeding further, a comprehensive analysis of the country-wise growth of each regional market, including North America, Latin America, Europe, and Asia-Pacific is provided in the research document. The industry is also segmented in terms of product, technique, material, and application to uncover the top revenue prospects going forward.
Besides, the research literature scrutinizes all the leading players in this domain, based on innovative launches, industrial penetration, production methods, distribution channels, and revenue generation. Key developments like mergers & acquisitions, collaboration & partnerships, and investments are documented in the report.
The global pharmaceutical membrane filtration market can be segmented based on product, technique, application, and geography. Based on product, the market has been classified into MCE membrane filters, coated cellulose acetate membrane filters, nylon membrane filters, PTFE membrane filters, PVDF membrane filters, and others. Based on technique, the pharmaceutical membrane filtration market has been divided into microfiltration, ultra-filtration, nano-filtration, cross-filtration, reverse osmosis, and ion exchange. Based on application, the market has been segmented into final product processing, raw material filtration, cell separation, water purification, and air purification.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Pharmaceutical Membrane Filtration market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Pharmaceutical Membrane Filtration market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
| Report Scope | Details |
| Market Size | USD 14.2 Billion by 2027 |
| Growth Rate | CAGR of 16.5% From 2021 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2021 to 2027 |
| Historic Data | 2017 to 2020 |
| Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
| Segments Covered | Product, Material, Technique, and Application |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | GEA Group, Koch Membrane Systems Inc., Graver Technologies, LLC, Alfa Laval, Sartorius Stedim Biotech Group, Pall Corporation, GE Healthcare Company, and Merck KGaA. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Pharmaceutical Membrane Filtration market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Market Opportunity analysis:
The commercial viability of track-etched membranes hinges on inexpensive production, suitable chemistries, scalable processing methods, and efficacy demonstration in real separation environments. Commercial ultrafiltration membranes are produced by phase-inversion processes that are time-consuming and need careful control. As a result, they are expensive and have poor structural definition and decreased separation selectivity.
Hence, combining these two technologies may provide the unique ability to purify, separate, and concentrate target molecules in continuous systems while at the same time being scalable up to the dimensions demanded by industrial separation processes. Modern membrane filtration technology utilizing ultrafiltration track-etch (1?100 nm) is an attractive solution to areas such as drinking water treatment, extractive industrial water treatment, industrial gas separation, domestic air filtration, and biochemical sensing, and could be used in preference to conventional separation methods
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Pharmaceutical Membrane Filtration Market include: GEA Group, Koch Membrane Systems Inc., Graver Technologies, LLC, Alfa Laval, Sartorius Stedim Biotech Group, Pall Corporation, GE Healthcare Company, and Merck KGaA.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Product
By Technique:
By Material
By Application
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Pharmaceutical Membrane Filtration market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Pharmaceutical Membrane Filtration market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Pharmaceutical Membrane Filtration markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Pharmaceutical Membrane Filtration market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Pharmaceutical Membrane Filtration Market, By Product
7.1. Pharmaceutical Membrane Filtration Market, By Product, 2021-2027
7.1.1. Filters
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Systems
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Accessories
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Pharmaceutical Membrane Filtration Market, By Technique
8.1. Pharmaceutical Membrane Filtration Market, By Technique, 2021-2027
8.1.1. Microfiltration
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Ultrafiltration
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Nanofiltration
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Reverse Osmosis
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Ion Exchange
8.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Pharmaceutical Membrane Filtration Market, By Material
9.1. Pharmaceutical Membrane Filtration Market, By Material, 2021-2027
9.1.1. PES
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. PVDF
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Nylon
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. PTFE
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. MCE & CA
9.1.5.1. Market Revenue and Forecast (2016-2027)
9.1.6. PCTE
9.1.6.1. Market Revenue and Forecast (2016-2027)
9.1.7. Other Materials
9.1.7.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Pharmaceutical Membrane Filtration Market, By Application
10.1. Pharmaceutical Membrane Filtration Market, By Application, 2021-2027
10.1.1. Final Product Processing
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Final Product Processing
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Cell Separation
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Water Purification
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Air Purification
10.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 11.Global Pharmaceutical Membrane Filtration Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.2. Market Revenue and Forecast, By Technique (2016-2027)
11.1.3. Market Revenue and Forecast, By Material (2016-2027)
11.1.4. Market Revenue and Forecast, By Application (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.5.2. Market Revenue and Forecast, By Technique (2016-2027)
11.1.5.3. Market Revenue and Forecast, By Material (2016-2027)
11.1.5.4. Market Revenue and Forecast, By Application (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.6.2. Market Revenue and Forecast, By Technique (2016-2027)
11.1.6.3. Market Revenue and Forecast, By Material (2016-2027)
11.1.6.4. Market Revenue and Forecast, By Application (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.2. Market Revenue and Forecast, By Technique (2016-2027)
11.2.3. Market Revenue and Forecast, By Material (2016-2027)
11.2.4. Market Revenue and Forecast, By Application (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.5.2. Market Revenue and Forecast, By Technique (2016-2027)
11.2.5.3. Market Revenue and Forecast, By Material (2016-2027)
11.2.5.4. Market Revenue and Forecast, By Application (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Product(2016-2027)
11.2.6.2. Market Revenue and Forecast, By Technique (2016-2027)
11.2.6.3. Market Revenue and Forecast, By Material (2016-2027)
11.2.6.4. Market Revenue and Forecast, By Application (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.7.2. Market Revenue and Forecast, By Technique (2016-2027)
11.2.7.3. Market Revenue and Forecast, By Material (2016-2027)
11.2.7.4. Market Revenue and Forecast, By Application (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.8.2. Market Revenue and Forecast, By Technique (2016-2027)
11.2.8.3. Market Revenue and Forecast, By Material (2016-2027)
11.2.8.4. Market Revenue and Forecast, By Application (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.2. Market Revenue and Forecast, By Technique (2016-2027)
11.3.3. Market Revenue and Forecast, By Material (2016-2027)
11.3.4. Market Revenue and Forecast, By Application (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.5.2. Market Revenue and Forecast, By Technique (2016-2027)
11.3.5.3. Market Revenue and Forecast, By Material (2016-2027)
11.3.5.4. Market Revenue and Forecast, By Application (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.6.2. Market Revenue and Forecast, By Technique (2016-2027)
11.3.6.3. Market Revenue and Forecast, By Material (2016-2027)
11.3.6.4. Market Revenue and Forecast, By Application (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.7.2. Market Revenue and Forecast, By Technique (2016-2027)
11.3.7.3. Market Revenue and Forecast, By Material (2016-2027)
11.3.7.4. Market Revenue and Forecast, By Application (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.8.2. Market Revenue and Forecast, By Technique (2016-2027)
11.3.8.3. Market Revenue and Forecast, By Material (2016-2027)
11.3.8.4. Market Revenue and Forecast, By Application (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.2. Market Revenue and Forecast, By Technique (2016-2027)
11.4.3. Market Revenue and Forecast, By Material (2016-2027)
11.4.4. Market Revenue and Forecast, By Application (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.5.2. Market Revenue and Forecast, By Technique (2016-2027)
11.4.5.3. Market Revenue and Forecast, By Material (2016-2027)
11.4.5.4. Market Revenue and Forecast, By Application (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.6.2. Market Revenue and Forecast, By Technique (2016-2027)
11.4.6.3. Market Revenue and Forecast, By Material (2016-2027)
11.4.6.4. Market Revenue and Forecast, By Application (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.7.2. Market Revenue and Forecast, By Technique (2016-2027)
11.4.7.3. Market Revenue and Forecast, By Material (2016-2027)
11.4.7.4. Market Revenue and Forecast, By Application (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.8.2. Market Revenue and Forecast, By Technique (2016-2027)
11.4.8.3. Market Revenue and Forecast, By Material (2016-2027)
11.4.8.4. Market Revenue and Forecast, By Application (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.2. Market Revenue and Forecast, By Technique (2016-2027)
11.5.3. Market Revenue and Forecast, By Material (2016-2027)
11.5.4. Market Revenue and Forecast, By Application (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.5.2. Market Revenue and Forecast, By Technique (2016-2027)
11.5.5.3. Market Revenue and Forecast, By Material (2016-2027)
11.5.5.4. Market Revenue and Forecast, By Application (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.6.2. Market Revenue and Forecast, By Technique (2016-2027)
11.5.6.3. Market Revenue and Forecast, By Material (2016-2027)
11.5.6.4. Market Revenue and Forecast, By Application (2016-2027)
Chapter 12. Company Profiles
12.1. GEA Group
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Koch Membrane Systems Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Graver Technologies
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. LLC
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Alfa Laval
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Sartorius Stedim Biotech Group
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Pall Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. GE Healthcare Company
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Merck KGaA.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers